IMCD updates sustainability targets, shares in focus on Euronext Amsterdam

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 19:37.

IMCD N.V. (NL0010801007) draws analyst attention this Tuesday with its role as a major specialty chemicals distributor on Euronext Amsterdam. The stock sits in a clear consensus picture for 2026 earnings and valuation, according to current analyst and data-provider overviews.IMCD investor information

What analysts see in IMCD

IMCD is covered by several European research houses that track its earnings growth, acquisition strategy and cash generation against peers like Brenntag and Azelis, which are also listed in Europe. Consensus data providers show a cluster of Buy and Hold ratings with dispersed price targets for the Amsterdam-listed shares.Danelfin AI view on IMCD

Recent AI-based analytics from Danelfin describe an AI score of 5 out of 10 for IMCD, equivalent to a Hold judgment in that framework, with an estimated 47.78 percent probability of beating the market over three months and a small negative gap versus the European average probability of 48.91 percent.Danelfin probability metrics

Consensus and valuation context this week

For 2026, analysts typically model continued revenue and earnings expansion for IMCD, driven by bolt-on acquisitions and organic growth in key end markets such as pharmaceuticals, food ingredients and industrial applications, while comparing margins and capital returns with Brenntag and Azelis. Many models monitor free cash flow conversion and net debt ratios to assess room for future deals and dividends.Reuters coverage of IMCD

The stock’s valuation in data overviews is typically compared to European distributors on earnings and EBITDA multiples, with investors watching whether IMCD trades at a premium for its asset-light model and diversification, or converges towards sector averages as market conditions normalize in chemicals distribution.Market-based IMCD data

The business behind the stock

IMCD generates its revenue by distributing and formulating specialty chemicals and ingredients for sectors including life sciences, food and nutrition, coatings and construction, advanced materials and industrial applications. The group operates an asset-light model with technical centers that support suppliers and customers on formulation and regulatory compliance.

Where the stock trades today

The IMCD shares (NL0010801007) trade on Euronext Amsterdam; the latest available data from exchange and financial portals show the listing in euros with a multi-billion-euro market capitalization for the specialty chemicals distributor.

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. All data are based on publicly available sources believed to be reliable but are not guaranteed for accuracy or completeness.